Tags

Type your tag names separated by a space and hit enter

Assay in serum of exchangeable copper and total copper using inductively coupled plasma mass spectrometry (ICP-MS): development, optimisation and evaluation of a routine procedure.
Scand J Clin Lab Invest. 2020 Dec; 80(8):630-639.SJ

Abstract

The assay in serum of non-caeruloplasmin copper, as exchangeable copper after complexation with EDTA (ExCu) and total copper has been evaluated and compared in patients with varying c-reactive protein(CRP). Measurement of ExCu and total copper, range 0.2-47.2 µmol/L, was developed using ICP-MS. The chelating agents EDTA and TEPA were compared over 0.0-10 g/L after incubation with serum for 60 mins followed by ultrafiltration with Amicon 10 kDa filter. The assay for ExCu was optimised with EDTA 3 g/L (8.1 mmol/L) maintained at pH 7.0-8.0 before ultrafiltration. TEPA was not as selective in chelation of copper. Patients n = 82 were studied in relation to changes in inflammatory marker CRP and a group of patients n = 37 with normal CRP. The ExCu assay gave excellent recoveries (94-102 % but poor recovery for free uncomplexed copper), good repeatability, limit of quantitation 0.19 µmol/l with a provisional reference range 0.48 to 1.63 µmol/L (n = 37 patients). The range for relative exchangeable copper (exchangeable copper divided by total serum copper) was 2.49 to 9.96 %. ExCu was elevated in conditions with increased CRP greater than 100 mg/L suggesting an effect of inflammation on the free copper fraction. A reliable and reproducible assay for ExCu and total copper has been developed. The upregulated inflammatory state increases the ExCu suggesting excess free copper.

Authors+Show Affiliations

Department of Clinical Biochemistry, Liverpool Clinical Laboratories, The Royal Liverpool and Broadgreen University Hospitals, Liverpool, UK.Department of Clinical Biochemistry, Liverpool Clinical Laboratories, The Royal Liverpool and Broadgreen University Hospitals, Liverpool, UK.Department of Clinical Biochemistry, Liverpool Clinical Laboratories, The Royal Liverpool and Broadgreen University Hospitals, Liverpool, UK.Department of Clinical Biochemistry, Liverpool Clinical Laboratories, The Royal Liverpool and Broadgreen University Hospitals, Liverpool, UK.

Pub Type(s)

Journal Article

Language

eng

PubMed ID

32955383

Citation

Daymond, Richard, et al. "Assay in Serum of Exchangeable Copper and Total Copper Using Inductively Coupled Plasma Mass Spectrometry (ICP-MS): Development, Optimisation and Evaluation of a Routine Procedure." Scandinavian Journal of Clinical and Laboratory Investigation, vol. 80, no. 8, 2020, pp. 630-639.
Daymond R, Curtis SL, Mishra V, et al. Assay in serum of exchangeable copper and total copper using inductively coupled plasma mass spectrometry (ICP-MS): development, optimisation and evaluation of a routine procedure. Scand J Clin Lab Invest. 2020;80(8):630-639.
Daymond, R., Curtis, S. L., Mishra, V., & Roberts, N. B. (2020). Assay in serum of exchangeable copper and total copper using inductively coupled plasma mass spectrometry (ICP-MS): development, optimisation and evaluation of a routine procedure. Scandinavian Journal of Clinical and Laboratory Investigation, 80(8), 630-639. https://doi.org/10.1080/00365513.2020.1821397
Daymond R, et al. Assay in Serum of Exchangeable Copper and Total Copper Using Inductively Coupled Plasma Mass Spectrometry (ICP-MS): Development, Optimisation and Evaluation of a Routine Procedure. Scand J Clin Lab Invest. 2020;80(8):630-639. PubMed PMID: 32955383.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Assay in serum of exchangeable copper and total copper using inductively coupled plasma mass spectrometry (ICP-MS): development, optimisation and evaluation of a routine procedure. AU - Daymond,Richard, AU - Curtis,Sarah L, AU - Mishra,Vinita, AU - Roberts,Norman B, Y1 - 2020/09/21/ PY - 2020/9/22/pubmed PY - 2021/10/12/medline PY - 2020/9/21/entrez KW - Free copper KW - ICP-MS KW - caeruloplasmin KW - exchangeable copper KW - non-caeruloplasmin copper KW - relative exchangeable copper KW - total copper KW - ultrafiltrable copper KW - ultrafiltration SP - 630 EP - 639 JF - Scandinavian journal of clinical and laboratory investigation JO - Scand J Clin Lab Invest VL - 80 IS - 8 N2 - The assay in serum of non-caeruloplasmin copper, as exchangeable copper after complexation with EDTA (ExCu) and total copper has been evaluated and compared in patients with varying c-reactive protein(CRP). Measurement of ExCu and total copper, range 0.2-47.2 µmol/L, was developed using ICP-MS. The chelating agents EDTA and TEPA were compared over 0.0-10 g/L after incubation with serum for 60 mins followed by ultrafiltration with Amicon 10 kDa filter. The assay for ExCu was optimised with EDTA 3 g/L (8.1 mmol/L) maintained at pH 7.0-8.0 before ultrafiltration. TEPA was not as selective in chelation of copper. Patients n = 82 were studied in relation to changes in inflammatory marker CRP and a group of patients n = 37 with normal CRP. The ExCu assay gave excellent recoveries (94-102 % but poor recovery for free uncomplexed copper), good repeatability, limit of quantitation 0.19 µmol/l with a provisional reference range 0.48 to 1.63 µmol/L (n = 37 patients). The range for relative exchangeable copper (exchangeable copper divided by total serum copper) was 2.49 to 9.96 %. ExCu was elevated in conditions with increased CRP greater than 100 mg/L suggesting an effect of inflammation on the free copper fraction. A reliable and reproducible assay for ExCu and total copper has been developed. The upregulated inflammatory state increases the ExCu suggesting excess free copper. SN - 1502-7686 UR - https://www.unboundmedicine.com/medline/citation/32955383/Assay_in_serum_of_exchangeable_copper_and_total_copper_using_inductively_coupled_plasma_mass_spectrometry__ICP_MS_:_development_optimisation_and_evaluation_of_a_routine_procedure_ DB - PRIME DP - Unbound Medicine ER -